Current and novel approaches to vaccine development against tuberculosis.

Frontiers in cellular and infection microbiology

Volumn 2, Issue , 2012, Pages 154-

  Cayabyab, Mark J ^a   Macovei, Lilia ^b   Campos Neto, Antonio ^b  

^a FORSYTH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ANTIGEN; BCG VACCINE; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN; VACCINE;

DELIVERY SYSTEM; DRUG DEVELOPMENT; HEALTH; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; REVIEW; TUBERCULOSIS; VACCINATION;

ADJUVANT; ANTIGEN; DELIVERY SYSTEM; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEIN; TUBERCULOSIS; VACCINE;

ADJUVANTS, IMMUNOLOGIC; DRUG DISCOVERY; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION; WORLD HEALTH;

MLCS; MLOWN;

EID: 84884209914     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2012.00154     Document Type: Review

References (0)